Market Performance and Analysis of Hong Kong Hot Stock Junzi Bio (02367.HK)

Junzi Bio (02367.HK) is a hot stock in the Hong Kong stock market, mainly based on the following dimensions:

1. Market Popularity and Trading Activities
   : Included in the East Money App Hong Kong Stock Popularity Ranking [Tushare dc_hot data source]. On December 1, 2025, a large sell order of 149,800 shares was executed at HK$36.58, involving approximately HK$5.48 million. The active trading has attracted attention [1].
2. Price and Market Performance
   : As of December 2, 2025, the current share price is HK$36.48, down 0.16% [0]. Year-to-date (YTD) gain is 25.66%, and 5-year return is 40.31%, far exceeding the Hang Seng Index’s 3.08% performance over the same period [0].
3. Fundamental Support
   : 2025 interim results show that profit attributable to shareholders was RMB 1.182 billion, a year-on-year increase of 20.23%, with earnings per share (EPS) of RMB 1.14, representing steady growth [2]. As a pioneer in the recombinant collagen field, it was listed on the Hong Kong Stock Exchange in November 2022 and is known as the “first recombinant collagen stock in Hong Kong” [3].

1. Industry Position and Market Attention
   : Junzi Bio’s leading position in the recombinant collagen field has made it a focus of market attention, and the growth in interim results has further strengthened investor confidence.
2. Impact of Large-Scale Transactions
   : The large sell order on December 1, 2025, is an important catalyst for recent stock price fluctuations and rising popularity, possibly reflecting profit-taking or position adjustments by some investors.
3. Contrast Between Long-Term and Short-Term Performance
   : In the long term, the company’s share price performance is strong, far exceeding the index level, but in the short term, it may fluctuate due to the impact of large-scale transactions.

1. Industry Competition Risk
   : It had a product quality dispute with medical beauty giant Bloomage Biotech in June 2025, which affected its share price at that time [3].
2. Valuation Volatility Risk
   : As a hot stock, increased trading volume may be accompanied by short-term price fluctuations.

1. Industry Growth Potential
   : The recombinant collagen market continues to grow, and the company, as a pioneer, is expected to benefit.
2. Steady Fundamentals
   : Growth in interim results provides support for the share price.

• Code: 02367.HK
• Name: Junzi Bio
• Current Price: HK$36.48 [0]
• YTD Performance: +25.66% [0]
• 5-Year Return: 40.31% [0]
• Interim Net Profit Growth: 20.23% [2]

The above analysis is based on public market data and industry information, providing an objective reference for decision-making.